Antisense makes sense in engineered regenerative medicine

Pharmaceutical Research

Volumn 26, Issue 2, 2009, Pages 263-275

  Yao, Yongchang ^a   Wang, Chunming ^a   Varshney, Rohan R ^a   Wang, Dong An ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Antisense; Oligodeoxynucleotides; Regenerative medicine; Ribozyme; RNA interference (RNAi)

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; RIBOZYME; SMALL INTERFERING RNA;

CELL VIABILITY; DEGENERATIVE DISEASE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENE THERAPY; GENETIC ENGINEERING; HUMAN; INJURY; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; RNA INTERFERENCE; STEM CELL; TISSUE ENGINEERING;

APOPTOSIS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; NERVE DEGENERATION; OLIGONUCLEOTIDES, ANTISENSE; REGENERATION; REGENERATIVE MEDICINE; RNA INTERFERENCE; RNA, CATALYTIC; RNA, SMALL INTERFERING; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 58549084364     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-008-9772-3     Document Type: Review

References (116)

1. G. C. Gurtner M. J. Callaghan M. T. Longaker 2007 Progress and potential for regenerative medicine Annu. Rev. Med. 58 299 312
2. G. C. Gurtner S. Werner Y. Barrandon M. T. Longaker 2008 Wound repair and regeneration Nature 453 314 321
3. S. J. Shieh J. P. Vacanti 2005 State-of-the-art tissue engineering: from tissue engineering to organ building Surgery 137 1 7
4. J. Pomerantz H. M. Blau 2004 Nuclear reprogramming: a key to stem cell function in regenerative medicine Nat. Cell Biol. 6 810 816
5. R. J. Trent I. E. Alexander 2004 Gene therapy: applications and progress towards the clinic Intern. Med. J. 34 621 625
6. D. A. Wang C. G. Williams F. Yang J. H. Elisseeff 2004 Enhancing the tissue-biomaterial interface: Tissue-initiated integration of biomaterials Adv. Funct. Mater. 14 1152 1159
7. T. Federici N. Boulis 2007 Gene therapy for peripheral nervous system diseases Curr. Gene Ther. 7 239 248
8. P. Sazani M. M. Vacek R. Kole 2002 Short-term and long-term modulation of gene expression by antisense therapeutics Curr. Opin. Biotechnol. 13 468 472
9. M. Khoury C. Jorgensen F. Apparailly 2007 RNAi in arthritis: prospects of a future antisense therapy in inflammation Curr. Opin. Mol. Ther. 9 483 489
10. M. L. Stephenson P. C. Zamecnik 1978 Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide Proc. Natl. Acad. Sci. U. S. A. 75 285 288
11. C. Guerrier-Takada K. Gardiner T. Marsh N. Pace S. Altman 1983 The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme Cell 35 849 857
12. A. C. Forster R. H. Symons 1987 Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites Cell 49 211 220
13. A. Hampel R. Tritz 1989 RNA catalytic properties of the minimum (-)sTRSV sequence Biochemistry 28 4929 4933
14. R. A. Collins B. J. Saville 1990 Independent transfer of mitochondrial chromosomes and plasmids during unstable vegetative fusion in Neurospora Nature 345 177 179
15. M. M. Lai 1995 The molecular biology of hepatitis delta virus Annu. Rev. Biochem. 64 259 286
16. L. Beigelman J. A. McSwiggen K. G. Draper C. Gonzalez K. Jensen A. M. Karpeisky A. S. Modak J. Matulic-Adamic A. B. DiRenzo P. Haeberli 1995 Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance J. Biol. Chem. 270 25702 25708
17. T. Kuwabara M. Warashina T. Tanabe K. Tani S. Asano K. Taira 1998 A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo Mol. Cell 2 617 627
18. C. J. Chen A. C. Banerjea G. G. Harmison K. Haglund M. Schubert 1992 Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication-potential effectiveness against most presently sequenced HIV-1 isolates Nucleic Acids Res. 20 4581 4589
19. M. Shiota M. Sano M. Miyagishi K. Taira 2004 Ribozymes: applications to functional analysis and gene discovery J. Biochem. 136 133 147
20. F. K. Askari W. M. McDonnell 1996 Antisense-oligonucleotide therapy N. Engl. J. Med. 334 316 318
21. P. Sazani R. Kole 2003 Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing J. Clin. Invest. 112 481 486
22. A. A. Levin 1999 A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides Biochim. Biophys. Acta 1489 69 84
23. M. I. Phillips Y. C. Zhang 2000 Basic principles of using antisense oligonucleotides in vivo Methods Enzymol. 313 46 56
24. S. T. Crooke K. M. Lemonidis L. Neilson R. Griffey E. A. Lesnik B. P. Monia 1995 Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes Biochem. J. 312 Pt 2 599 608
25. J. Kurreck E. Wyszko C. Gillen V. A. Erdmann 2002 Design of antisense oligonucleotides stabilized by locked nucleic acids Nucleic Acids Res. 30 1911 1918
26. T. A. Vickers S. Koo C. F. Bennett S. T. Crooke N. M. Dean B. F. Baker 2003 Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis J. Biol. Chem. 278 7108 7118
27. B. F. Baker S. S. Lot T. P. Condon S. Cheng-Flournoy E. A. Lesnik H. M. Sasmor C. F. Bennett 1997 2?-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells J. Biol. Chem. 272 11994 12000
28. A. Fire S. Xu M. K. Montgomery S. A. Kostas S. E. Driver C. C. Mello 1998 Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 806 811
29. S. M. Elbashir J. Harborth W. Lendeckel A. Yalcin K. Weber T. Tuschl 2001 Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 494 498
30. T. Tuschl P. D. Zamore R. Lehmann D. P. Bartel P. A. Sharp 1999 Targeted mRNA degradation by double-stranded RNA in vitro Genes Dev. 13 3191 3197
31. P. D. Zamore T. Tuschl P. A. Sharp D. P. Bartel 2000 RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals Cell 101 25 33
32. S. M. Hammond E. Bernstein D. Beach G. J. Hannon 2000 An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells Nature 404 293 296
33. T. R. Brummelkamp R. Bernards R. Agami 2002 A system for stable expression of short interfering RNAs in mammalian cells Science 296 550 553
34. G. Sui C. Soohoo B. Affar el F. Gay Y. Shi W. C. Forrester Y. Shi 2002 A DNA vector-based RNAi technology to suppress gene expression in mammalian cells Proc. Natl. Acad. Sci. U. S. A. 99 5515 5520
35. P. J. Paddison A. A. Caudy E. Bernstein G. J. Hannon D. S. Conklin 2002 Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells Genes Dev. 16 948 958
36. P. D. Zamore N. Aronin 2003 siRNAs knock down hepatitis Nat. Med. 9 266 267
37. P. C. Scacheri O. Rozenblatt-Rosen N. J. Caplen T. G. Wolfsberg L. Umayam J. C. Lee C. M. Hughes K. S. Shanmugam A. Bhattacharjee M. Meyerson F. S. Collins 2004 Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells Proc. Natl. Acad. Sci. U. S. A. 101 1892 1897
38. A. L. Jackson J. Burchard D. Leake A. Reynolds J. Schelter J. Guo J. M. Johnson L. Lim J. Karpilow K. Nichols W. Marshall A. Khvorova P. S. Linsley 2006 Position-specific chemical modification of siRNAs reduces "off- target" transcript silencing RNA 12 1197 1205
39. Y. Zeng R. Yi B. R. Cullen 2003 MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms Proc. Natl. Acad. Sci. U. S. A. 100 9779 9784
40. J. G. Doench C. P. Petersen P. A. Sharp 2003 siRNAs can function as miRNAs Genes Dev. 17 438 442
41. E. van Rooij E. N. Olson 2007 MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets J. Clin. Invest. 117 2369 2376
42. M. Puceat 2008 Pharmacological approaches to regenerative strategies for the treatment of cardiovascular diseases Curr. Opin. Pharmacol. 8 189 192
43. K. M. Kurian C. J. Watson A. H. Wyllie 2000 Retroviral vectors Mol. Pathol. 53 173 176
44. L. D. Kumar A. R. Clarke 2007 Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications Adv. Drug Deliv. Rev. 59 87 100
45. J. M. Adams S. Cory 2001 Life-or-death decisions by the Bcl-2 protein family Trends Biochem. Sci. 26 61 66
46. M. Chen J. Wang 2002 Initiator caspases in apoptosis signaling pathways Apoptosis 7 313 319
47. G. B. Carey D. Donjerkovic C. M. Mueller S. Liu J. A. Hinshaw L. Tonnetti W. Davidson D. W. Scott 2000 B-cell receptor and Fas-mediated signals for life and death Immunol. Rev. 176 105 115
48. J. F. Curtin T. G. Cotter 2003 Live and let die: regulatory mechanisms in Fas-mediated apoptosis Cell. Signal. 15 983 992
49. D. Klein C. Ricordi A. Pugliese R. L. Pastori 2000 Inhibition of Fas-mediated apoptosis in mouse insulinoma beta TC-3 cells via an anti-Fas ribozyme Hum. Gene Ther. 11 1033 1045
50. V. Arora P. L. Iversen 2000 Antisense oligonucleotides targeted to the p53 gene modulate liver regeneration in vivo Drug Metab. Dispos. 28 131 138
51. L. Magnelli M. Ruggiero V. Chiarugi 1997 The old and the new in p53 functional regulation Biochem. Mol. Med. 62 3 10
52. H. T. Mao Q. Liu J. Zhang H. T. Gu L. Wang X. B. Zhou H. P. Yin L. Zhang F. X. Xie G. S. Jiang 2007 Effects of specific antisense oligonucleotide inhibition of Fas expression on T cell apoptosis induced by Fas ligand International Immunopharmacology 7 1714 1722
53. A. H. Insua A. D. Montaner J. M. Rodriguez F. Elias J. Flo R. A. Lopez J. Zorzopulos E. L. Hofer N. A. Chasseing 2007 IMT504, the prototype of the immunostimulatory oligonucleotides of the PyNTTTTGT class, increases the number of progenitors of mesenchymal stem cells both in vitro and in vivo: potential use in tissue repair therapy Stem Cells 25 1047 1054
54. R. Mussmann M. Geese F. Harder S. Kegel U. Andag A. Lomow U. Burk D. Onichtchouk C. Dohrmann M. Austen 2007 Inhibition of GSK3 promotes replication and survival of pancreatic beta cells J. Biol. Chem. 282 12030 12037
55. S. Chen J. H. Ding R. Bekeredjian B. Z. Yang R. V. Shohet S. A. Johnston H. E. Hohmeier C. B. Newgard P. A. Grayburn 2006 Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology Proc. Natl. Acad. Sci. U. S. A. 103 8469 8474
56. D. B. Ring K. W. Johnson E. J. Henriksen J. M. Nuss D. Goff T. R. Kinnick S. T. Ma J. W. Reeder I. Samuels T. Slabiak A. S. Wagman M. E. Hammond S. D. Harrison 2003 Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo Diabetes 52 588 595
57. H. Song Z. Zhang L. Wang 2008 Small interference RNA against PTP-1B reduces hypoxia/reoxygenation induced apoptosis of rat cardiomyocytes Apoptosis 13 383 393
58. P. Lingor P. Koeberle S. Kugler M. Bahr 2005 Down-regulation of apoptosis mediators by RNAi inhibits axotomy-induced retinal ganglion cell death in vivo Brain 128 550 558
59. F. Li R. I. Mahato 2008 iNOS gene silencing prevents inflammatory cytokine-induced beta-cell apoptosis Mol. Pharm. 5 407 417
60. B. Brune A. von Knethen K. B. Sandau 1998 Nitric oxide and its role in apoptosis Eur. J. Pharmacol. 351 261 272
61. W. P. Arend J. M. Dayer 1990 Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis Arthritis Rheum. 33 305 315
62. M. Feldmann F. M. Brennan R. N. Maini 1996 Role of cytokines in rheumatoid arthritis Annu. Rev. Immunol. 14 397 440
63. M. Feldmann R. N. Maini 2001 Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19 163 196
64. J. Saklatvala 1986 Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage Nature 322 547 549
65. F. M. Brennan A. Jackson D. Chantry R. Maini M. Feldmann 1989 Inhibitory effect of Tnf-alpha antibodies on synovial cell interleukin-1 production in rheumatoid-arthritis Lancet 2 244 247
66. C. Haworth F. M. Brennan D. Chantry M. Turner R. N. Maini M. Feldmann 1991 Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid-arthritis - regulation by tumor-necrosis-factor-alpha Eur. J. Immunol. 21 2575 2579
67. R. O. Williams M. Feldmann R. N. Maini 1992 Antitumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proc. Natl. Acad. Sci. U. S. A. 89 9784 9788
68. J. Keffer L. Probert H. Cazlaris S. Georgopoulos E. Kaslaris D. Kioussis G. Kollias 1991 Transgenic mice expressing human tumor-necrosis-factor - a predictive genetic model of arthritis Embo J. 10 4025 4031
69. M. Takahashi T. Funato Y. Suzuki H. Fujii K. K. Ishii M. Kaku T. Sasaki 2002 Chemically modified ribozyme targeting TNF-alpha mRNA regulates TNF-alpha and IL-6 synthesis in synovial fibroblasts of patients with rheumatoid arthritis J. Clin. Immunol. 22 228 236
70. R. Kumar V. Dammai P. K. Yadava S. Kleinau 2005 Gene targeting by ribozyme against TNF-alpha mRNA inhibits autoimmune arthritis Gene Ther 12 1486 1493
71. M. Karin M. Delhase 2000 The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling Semin. Immunol. 12 85 98
72. M. A. Collart P. Baeuerle P. Vassalli 1990 Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B Mol. Cell. Biol. 10 1498 1506
73. T. A. Libermann D. Baltimore 1990 Activation of interleukin-6 gene expression through the NF-kappa B transcription factor Mol. Cell. Biol. 10 2327 2334
74. R. Marok P. G. Winyard A. Coumbe M. L. Kus K. Gaffney S. Blades P. I. Mapp C. J. Morris D. R. Blake C. Kaltschmidt P. A. Baeuerle 1996 Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue Arthritis Rheum. 39 583 591
75. T. Tomita E. Takeuchi N. Tomita R. Morishita M. Kaneko K. Yamamoto T. Nakase H. Seki K. Kato Y. Kaneda T. Ochi 1999 Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy Arthritis Rheum. 42 2532 2542
76. L. X. Chen L. Lin H. J. Wang X. L. Wei X. Fu J. Y. Zhang C. L. Yu 2008 Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA Osteoarthr. Cartil. 16 174 184
77. J. Schedel C. A. Seemayer T. Pap M. Neidhart S. Kuchen B. A. Michel R. E. Gay U. Muller-Ladner S. Gay W. Zacharias 2004 Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis Gene Ther. 11 1040 1047
78. E. Rutkauskaite W. Zacharias J. Schedel U. Muller-Ladner C. Mawrin C. A. Seemayer D. Alexander R. E. Gay W. K. Aicher B. A. Michel S. Gay T. Pap 2004 Ribozymes that inhibit the production of matrix metalloproteinase 1 reduce the invasiveness of rheumatoid arthritis synovial fibroblasts Arthritis Rheum. 50 1448 1456
79. Y. Smicun M. W. Kilpatrick J. Florer I. Toudjarska G. Wu R. J. Wenstrup P. Tsipouras 2003 Enhanced intracellular availability and survival of hammerhead ribozymes increases target ablation in a cellular model of osteogenesis imperfecta Gene Ther. 10 2005 2012
80. E. Gazzerro A. Smerdel-Ramoya S. Zanotti L. Stadmeyer D. Durant A. N. Economides E. Canalis 2007 Conditional deletion of gremlin causes a transient increase in bone formation and bone mass J. Biol. Chem. 282 31549 31557
81. R. Zwicky K. Muntener M. B. Goldring A. Baici 2002 Cathepsin B expression and down-regulation by gene silencing and antisense DNA in human chondrocytes Biochem. J. 367 209 217
82. L. Dong R. Wang Y. A. Zhu C. Wang H. Diao C. Zhang J. Zhao J. Zhang 2008 Antisense oligonucleotide targeting TNF-alpha can suppress Co-Cr-Mo particle-induced osteolysis J. Orthop. Res. 26 1114 1120
83. R. Natarajan F. N. Salloum B. J. Fisher R. C. Kukreja A. A. Fowler 3rd 2006 Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury Circ. Res. 98 133 140
84. R. Natarajan F. N. Salloum B. J. Fisher E. D. Ownby R. C. Kukreja A. A. Fowler 3rd 2007 Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium Am. J. Physiol. Heart Circ. Physiol. 293 H1571 H1580
85. R. Natarajan F. N. Salloum B. J. Fisher R. C. Kukreja A. A. Fowler 3rd 2008 Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury J. Cardiovasc. Pharmacol. 51 178 187
86. A. Watanabe M. Arai M. Yamazaki N. Koitabashi F. Wuytack M. Kurabayashi 2004 Phospholamban ablation by RNA interference increases Ca2+ uptake into rat cardiac myocyte sarcoplasmic reticulum J. Mol. Cell. Cardiol. 37 691 698
87. H. Fechner L. Suckau J. Kurreck I. Sipo X. Wang S. Pinkert S. Loschen J. Rekittke S. Weger D. Dekkers R. Vetter V. A. Erdmann H. P. Schultheiss M. Paul J. Lamers W. Poller 2007 Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban Gene Ther. 14 211 218
88. J. C. Braz K. Gregory A. Pathak W. Zhao B. Sahin R. Klevitsky T. F. Kimball J. N. Lorenz A. C. Nairn S. B. Liggett I. Bodi S. Wang A. Schwartz E. G. Lakatta A. A. DePaoli-Roach J. Robbins T. E. Hewett J. A. Bibb M. V. Westfall E. G. Kranias J. D. Molkentin 2004 PKC-alpha regulates cardiac contractility and propensity toward heart failure Nat. Med. 10 248 254
89. A. El-Armouche J. Singh H. Naito K. Wittkopper M. Didie A. Laatsch W. H. Zimmermann T. Eschenhagen 2007 Adenovirus-delivered short hairpin RNA targeting PKCalpha improves contractile function in reconstituted heart tissue J. Mol. Cell. Cardiol. 43 371 376
90. H. Hayashita-Kinoh M. Yamada T. Yokota Y. Mizuno H. Mochizuki 2006 Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model Biochem. Biophys. Res. Commun. 341 1088 1095
91. Z. Ahmed R. G. Dent E. L. Suggate L. B. Barrett R. J. Seabright M. Berry A. Logan 2005 Disinhibition of neurotrophin-induced dorsal root ganglion cell neurite outgrowth on CNS myelin by siRNA-mediated knockdown of NgR, p75NTR and Rho-A Mol. Cell. Neurosci. 28 509 523
92. A. Pfeifer S. Eigenbrod S. Al-Khadra A. Hofmann G. Mitteregger M. Moser U. Bertsch H. Kretzschmar 2006 Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice J. Clin. Invest. 116 3204 3210
93. R. Morosetti M. Mirabella C. Gliubizzi A. Broccolini L. De Angelis E. Tagliafico M. Sampaolesi T. Gidaro M. Papacci E. Roncaglia S. Rutella S. Ferrari P. A. Tonali E. Ricci G. Cossu 2006 MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle Proc. Natl. Acad. Sci. U. S. A. 103 16995 17000
94. J. Machen J. Harnaha R. Lakomy A. Styche M. Trucco N. Giannoukakis 2004 Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells J. Immunol. 173 4331 4341
95. B. Phillips K. Nylander J. Harnaha J. Machen R. Lakomy A. Styche K. Gillis L. Brown D. Lafreniere M. Gallo J. Knox K. Hogeland M. Trucco N. Giannoukakis 2008 A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes Diabetes 57 1544 1555
96. Y. B. Hu D. G. Li H. M. Lu 2007 Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats J. Gene Med. 9 217 229
97. Y. M. Chae K. K. Park I. K. Lee J. K. Kim C. H. Kim Y. C. Chang 2006 Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction Gene Ther. 13 430 439
98. M. F. Cordeiro A. Mead R. R. Ali R. A. Alexander S. Murray C. Chen C. York-Defalco N. M. Dean G. S. Schultz P. T. Khaw 2003 Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome Gene Ther. 10 59 71
99. C. H. Heldin K. Miyazono P. ten Dijke 1997 TGF-beta signalling from cell membrane to nucleus through SMAD proteins Nature 390 465 471
100. Z. Y. Gao Z. M. Wang Y. Shi Z. H. Lin H. Jiang T. S. Hou Q. G. Wang X. B. Yuan Y. Z. Zhao H. Wu Y. X. Jin 2006 Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA Plast. Reconstr. Surg. 118 1328 1337
101. Z. Wang Z. Gao Y. Shi Y. Sun Z. H. Lin H. Jiang T. S. Hou Q. G. Wang X. B. Yuan X. H. Zhu H. Wu Y. X. Jin 2007 Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts J. Plast. Reconstr. Aesthet. Surg. 60 1193 1199
102. J. Silver J. H. Miller 2004 Regeneration beyond the glial scar Nat. Rev. Neurosci. 5 146 156
103. T. L. Laabs H. Wang Y. Katagiri T. McCann J. W. Fawcett H. M. Geller 2007 Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans J. Neurosci. 27 14494 14501
104. J. A. Bradley E. M. Bolton R. A. Pedersen 2002 Stem cell medicine encounters the immune system Nat. Rev. Immunol. 2 859 871
105. C. Figueiredo A. Seltsam R. Blasczyk 2006 Class-, gene-, and group-specific HLA silencing by lentiviral shRNA delivery J. Mol. Med. 84 425 437
106. C. Figueiredo P. A. Horn R. Blasczyk A. Seltsam 2007 Regulating MHC expression for cellular therapeutics Transfusion 47 18 27
107. K. Haga N. A. Lemp C. R. Logg J. Nagashima E. Faure-Kumar G. G. Gomez C. A. Kruse R. Mendez R. Stripecke N. Kasahara J. C. Cicciarelli 2006 Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: averting cytotoxicity by alloreactive T lymphocytes Transplant. Proc. 38 3184 3188
108. W. H. Hancock W. D. Whitley S. G. Tullius U. W. Heemann B. Wasowska W. M. Baldwin 3rd N. L. Tilney 1993 Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts Transplantation 56 643 650
109. D. Dragun I. Lukitsch S. G. Tullius Y. Qun J. K. Park W. Schneider F. C. Luft H. Haller 1998 Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat Kidney Int. 54 2113 2122
110. R. S. Poston M. J. Mann E. G. Hoyt M. Ennen V. J. Dzau R. C. Robbins 1999 Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method Transplantation 68 825 832
111. B. Johnstone T. M. Hering A. I. Caplan V. M. Goldberg J. U. Yoo 1998 In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells Exp. Cell Res. 238 265 272
112. A. Vats R. C. Bielby N. Tolley S. C. Dickinson A. R. Boccaccini A. P. Hollander A. E. Bishop J. M. Polak 2006 Chondrogenic differentiation of human embryonic stem cells: the effect of the micro-environment Tissue Eng. 12 1687 1697
113. S. A. Lietman, C. Ding, D. W. Cooke, and M. A. Levine. Reduction in Gsalpha induces osteogenic differentiation in human mesenchymal stem cells. Clin. Orthop. Relat. Res. (434):231-238 (2005). doi: 10.1097/01.blo.0000153279. 90512.38.
114. D. Wegmuller I. Raineri B. Gross E. J. Oakeley C. Moroni 2007 A cassette system to study embryonic stem cell differentiation by inducible RNA interference Stem Cells 25 1178 1185
115. Y. Xu S. H. Mirmalek-Sani X. Yang J. Zhang R. O. Oreffo 2006 The use of small interfering RNAs to inhibit adipocyte differentiation in human preadipocytes and fetal-femur-derived mesenchymal cells Exp. Cell Res. 312 1856 1864
116. P. Zhang M. J. Pazin C. M. Schwartz K. G. Becker R. P. Wersto C. M. Dilley M. P. Mattson 2008 Nontelomeric TRF2-REST interaction modulates neuronal gene silencing and fate of tumor and stem cells Curr. Biol. 18 19 1489 1494